{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-405.31",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 405.31 - Living donor transplantation services",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 405.31 - Living donor transplantation services\n\nState Regulations\n\nHospitals performing living donor transplants shall\ncomply with the requirements of this section, section\n405.30\nand with section\n405.22\n(a) of this\n\nPart. In addition, the following standards apply to all living donor transplant\nservices: (a) Definition. (1)\n\nDonor advocate\nis a\nperson or a team responsible for ensuring that the rights and interests of the\nliving donor and the prospective living donor are\nprotected. (b) Donor advocate responsibilities. A donor advocate shall be established for any living\ndonor transplantation program. The transplant program shall, as appropriate, consult with an ethicist, and a psychiatrist or other qualified mental health\nprofessional, as defined in section\n405.30\n(a)(6)\nof\nthis Part. The donor advocate's primary responsibility is to support the donor, beginning with the donor evaluation process and continuing through donation, the postoperative period, and discharge, and to ensure that there are\nappropriate referrals for post discharge care. The advocate shall assist the\ndonor in making informed decisions and balancing external/family pressures to\ndonate. The advocate must evaluate the donor and make a recommendation\nconcerning donor suitability and ensure that the needs of the donor are\nfulfilled promptly and in accordance with best medical practice. The advocate\nshall: (1)\nadvocate for the interests\nand well-being of the donor; (2)\nexplain the evaluation process, what to expect, what it means to be a\ndonor; (3)\nverify that such living\ndonor is at least 18 years of age at the time of such donor's initial\nevaluation related to the transplant procedure or is a parent donating to his\nor her child; (4)\nensure all\ndecisions made by the donor are informed and not coerced by: (i) evaluating whether there is monetary or\nproperty enrichment for the donor, and ensuring the donor signs an attestation\nas specified in paragraph (4) of this subdivision; (ii)\nevaluating whether there is overt\ncoercion to donate by family or others; (iii)\nassessing the donor's intellectual and\nemotional capability of participating in a balanced discussion of potential\nrisks and benefits; (iv)\nproviding\ninformation to the donor about the medical, psychosocial, and financial\nimplications of the living donation for the potential donor and about the\nrecipient's options for deceased donation transplant, including risks and\noutcomes; (v) ensuring the donor\nunderstands that he or she may decline to donate at any time prior to his or\nher surgery; and\n(vi)\nif requested\nby the donor, assisting the donor in the preparation of a general, medically\naccurate statement of unsuitability for donation. (5)\nconsult with the surgical team regarding\ndonor suitability before issuing a formal recommendation; (6)\ntransmit donor advocate findings in\nwriting to the surgical team. The transmittal shall include the reasons for the\ndonor advocate's recommendation. The final determination of donor suitability\nrests with the attending surgeons of the surgical team; (7)\nthe potential donor will be advised of\nthe donor advocate's recommendation. At least one attending surgeon and the\ndonor advocate shall make themselves available to the potential donor upon his\nor her request to discuss the donor advocate's recommendation; and\n(8)\nassure there is continuity of care during\nhospitalization and assure that there are appropriate referrals for\npost-discharge care. (c) Donor advocate requirements. (1)\n\nSuch donor advocate or, in the case of multiple members of a donor advocate\nteam at least one member of such team, must not participate in the care of\ntransplant recipients. The advocate's interests shall be centered on the\nwell-being of the living donor. (2)\n\nThe donor advocate shall not receive any direct or indirect benefit from\nrecommending continuation of the donor's participation. (3)\n\nThe status of the donor advocate at the\ntransplant center may not be affected by recommending for or against\ndonation. (4)\n\nThe donor advocate\nshall be medically sophisticated in transplantation and aware of relevant\nstatistics such as center volume and outcome data, and be able to explain such\ninformation to the potential donor. (5)\n\nThe donor advocate shall have sufficient\npreparation in his or her role to recommend that a specific donor is or is not\na candidate for living donation. (6)\n\nThe donor advocate shall have a\ncomprehensive working knowledge of living donor\ntransplantation. (d) Education of the donor. In order to ensure that the potential donor has the\nknowledge and capacity to exercise informed consent, the advocate shall do the\nfollowing: (1)\nconsider the\nintellectual and emotional capacity of the potential donor to exercise legally\nand ethically adequate informed consent as described in subdivision (e) of this\nsection; (2)\ninform him or her\norally and in writing about the risks and benefits of medical\ninterventions; (3)\nevaluate whether\nthere is a thorough understanding of the elements of the decision; (4)\nevaluate whether the potential donor's\ndecision is voluntary; (5)\ninform\nthe potential donor that the donor advocate may recommend against donation and\nthat the advocate's recommendation will be given significant consideration in\nthe surgical team's decision. The reasons for the advocate's decision shall be\nexplained to the donor; and\n(6)\nadvise the potential donor of the opportunity to discuss donation with others\nwho have donated in the past and assist in making arrangements to do so, if\nrequested by the donor. (e) Informed consent. A person who gives consent to be a living donor shall be\ncompetent, willing to donate, free from coercion, medically and psychosocially\nsuitable, fully informed of the risks and benefits as a donor, fully informed\nof the risks, benefits and any alternative treatments available to the\nrecipient, at least 18 years of age at the time of the donor's initial\nevaluation related to the transplant procedure unless the person is a parent\nseeking to donate to their own child, and be likely to benefit in a way not\ninvolving the transfer of money or property in connection with the donation, other than reimbursement of donation-related expenses as allowed by law. The\ninformed consent process must include: (1)\ninformed understanding: (i) presentation of all information to the\npotential donor in a language or manner understandable to him or her, consistent with his or her education level; (ii)\nthe potential donor shall be given the\nopportunity and adequate time to assimilate the information provided, ask\nquestions and have questions answered; (iii)\nthe donor shall identify the family and\nloved ones who shall be given the opportunity to discuss openly with the donor\nadvocate and the surgical team their concerns in a safe and non-threatening\nenvironment; and\n(iv)\nthe potential\ndonor shall be informed with regard to the need for postoperative, long-term\nfollow-up and testing by the transplant center. The donor shall also be\nprovided with information regarding the need and importance for long term\nfollow-up and annual primary care. (f) Disclosure requirements. (1)\n\nThe donation process shall be explained\nto the potential donor. This explanation shall address, at a minimum: (i) donor evaluation procedure; (ii)\nsurgical procedure; (iii)\nrecuperative period; (iv)\nshort and long term follow-up\ncare; (v) alternative donation and\ntransplant procedures; (vi)\npotential psychological benefits and detriments to the donor; (vii)\ntransplant center and surgeon specific\nstatistics of donor and recipient outcomes; (viii)\nconfidentiality of the donor's\ninformation and decision; (ix)\ndonor's ability to opt out at any point in the process up to the time of\nsurgery; and\n(x) information about\nhow the transplant center will follow the health of the donor for at least two\nyears post donation. (2)\n\nThe transplant team and the donor advocate shall disclose their institutional\naffiliations to the potential donor. (g) Risks. Risks shall be fully explained to the potential donor. The explanation shall include: (1)\nphysical: (i) potential for surgical\ncomplications including risk of donor death; (ii)\npotential for organ failure and the need\nfor transplantation; (iii)\npotential for other medical complications including long-term\ncomplications; (iv)\nscars; (v) pain; (vi)\nfatigue; (vii)\nabdominal and/or bowel symptoms such as\nbloating and nausea; (2)\npsychosocial: (i) potential for problems with\nbody image; (ii)\npossibility of\nrecipient death; (iii)\npossibility\nof recipient rejection and need for retransplantation; (iv)\npossibility of recurrent disease in the\nrecipient; (v) possibility of\nadjustment disorder post-surgery; (vi)\npossible impact on donor's\nfamily; (vii)\npossible impact on\nrecipient's family; and\n(viii)\npotential impact of donation on the donor's lifestyle. (3)\n\nFinancial: (i) out of pocket expenses; (ii)\npossible loss of employment; (iii)\npotential impact on ability to obtain\nfuture employment; (iv)\npotential\nfor disability benefits and need for assistance completing relevant paperwork; and\n(v) possible impact on ability\nto obtain health and life insurance. (h) Documentation. The entire disclosure and consent process, including the\nattestation required by section\n405.30\n(b)(8)\nof\nthis Part shall be documented in the donor's medical record, which shall be\nmaintained separate and distinct from the recipient's medical\nrecord. (i) Primary\nmedical evaluation. A medical evaluation of the potential donor shall be made\nby an appropriate medical physician. Appropriate laboratory and imaging studies\nshall be done. Additionally, the following shall also be assessed: (1)\ncompatibility of the potential donor to\nthe recipient; (2)\ngeneral health\nof, and surgical risk for, the potential donor; (3)\nco-morbidities and significant medical\nconditions that impact the potential donor's suitability; (4)\nthe potential donor's vulnerability to\ninfection, blood loss, or delayed wound healing; and the potential donor's\npersonal and family medical history. (j) Psychosocial. (1)\nA psychosocial evaluation of the\npotential donor shall be made by the qualified mental health professional, as\ndefined in section\n405.30\n(a)(6)\nof\nthis Title. The evaluation shall include, but not be limited to: consideration\nof the donor's current and past history of: any psychiatric illness, physical\nabuse, sexual abuse, alcohol abuse, and substance abuse. (2)\n\nSocial services shall be provided in\naccordance with section\n405.28\nof this Part as well as any\nadditional requirements established in this Part. (k) Recipient criteria. The transplant center must establish written policies and\nprocedures governing recipient eligibility for living donation. At a minimum, such policies and procedures shall: (1)\nensure the patient meets the center's\nwritten eligibility criteria as specified in section\n405.30\n(b)(5) and\n(e) of this Part; (2)\nensure the recipient has received\ninformation regarding specific risks and benefits, alternative treatments and\nexpected outcome of the transplantation; (3)\nestablish conditions which require\nrecipient exclusion; and\n(4)\nensure\nthat the benefits to both the donor and the recipient outweigh the risks before\nany living transplant is performed. (l) Donor management. (1)\n\nThe donor surgeon shall have the primary\nresponsibility for the donor's care and welfare throughout his or her hospital\nstay. (i) The donor surgeon is responsible\nfor making the final determination regarding a donor's suitability after\nreviewing and considering the donor's medical, psychological, and social\nhistory; the donor's current medical, psychological and social status; the\nrecommendation of the donor advocate, all consultative reports; and the\nstandards set forth in this subdivision. (ii)\n\nIf the donor surgeon decides to proceed\nwith a donation after receiving an adverse recommendation from the donor\nadvocate, the surgeon shall document the reasons for doing so in the patient's\nmedical record. (m) Imaging service\nrequirements. Hospitals performing living donor transplantation shall\nhave adequate imaging services and staff support appropriate to evaluate\nrecipients and living donors. Radiologists with experience in interventional\nprocedures (angiography) and ultrasound imaging studies in the living donor and\nrecipient, must be available at all times including weekends and holidays. If\nthere is an emergent complication requiring imaging services, these patients\nshould be prioritized for access to such imaging services by the\nhospital. (n) Discharge planning requirements. The hospital shall comply with the discharge planning\nrequirements contained in section\n405.9\nof this Part as well as the\nfollowing: (1)\n\nThe donor advocate\nshall be available to the donor from pre-admission to post-discharge. (2)\nA detailed, written discharge plan shall\nbe developed, given to the donor and provided to all health care professionals\ninvolved in the donor's care, including the donor's primary care\nphysician. (3)\n\nThis plan shall be\nreviewed with the donor by a health care professional such as a registered\nprofessional nurse, qualified social worker or transplant\ncoordinator. (4)\n\nThe plan shall\ninclude, at a minimum, instructions on: (i) activities; (ii)\ndiet; (iii)\nmedication for pain; and\n(iv)\nwound care. (5)\n\nThe patient shall be provided with a\n24-hour contact number that he/she can call with questions. The responder shall\nbe available when needed and knowledgeable about living donation. (6)\n\nInformation shall include the name, address and telephone number of the surgeon and instructions for the follow-up\nvisit. (7)\n\nInstructions for family\nmembers or caregivers shall be provided. (o) Post-discharge requirements. (1)\n\nMedical follow-up shall meet generally\naccepted standards for someone who has undergone a major transplant procedure. This follow-up shall include: (i) postoperative visits with the donor's surgeon(s); (ii)\nfollow-up coordinated with the donor's\nprimary care physician to assess wound healing and to monitor for\nsigns/symptoms of infection; (iii)\nlaboratory studies as appropriate; and\n(iv)\na written summary of the donor's\ncondition, which shall be provided to the donor and his or her primary care\nphysician upon the donor's discharge from the hospital. (2)\n\nThe hospital shall provide or arrange for\nfollow-up social/psychological supports directly related to the donation as\nneeded, which may include measures such as: (i) visits with a social worker familiar with\norgan transplantation issues; (ii)\nvisits with a psychologist or psychiatrist familiar with organ transplantation\nissues; (iii)\nparticipation in a\nprofessionally run support group; (iv)\nparticipation in a center sponsored\ncomputer donor listserve or bulletin board to share patient concerns; and\n(v) invitation to a donor\nrecognition event, such as an annual recognition ceremony or presentation of a\ndonor medal. (3)\n\nDonors\nshall be informed of the option to discuss financial/insurance concerns with\nthe transplant center's financial coordinator. (4)\n\nHospitals shall report to the department\nsuch information as the department shall require to assist the department in\nassessing the quality of care provided; determining routine or unusual\ncomplications or outcomes, and identifying potential improvements to donor\neducation, screening, consent, preoperative, surgical and postoperative care\nand follow-up. Such information shall include, but not be limited to: (i) donor demographics; (ii)\npreoperative medical and psychosocial\ninformation; (iii)\nsurgical\ninformation and complications; (iv)\nhospital staff training and experience; (v) recipient outcome; and\n(vi)\nimmediate and long-term postoperative\ncare, complications, and impact on quality of life. (5)\n\nHospitals shall track the donor and his\nor her condition for at least two years post donation in accordance with the\nprovisions set forth in section\n405.30\n(b)(9)\nof\nthis Part. (p) Living adult donor to adult recipient liver transplantation\nservices. (1)\n\nSurgical team\nrequirements: (i) At least two liver\ntransplant attending surgeons with experience as established in subparagraph\n(v) of this paragraph shall participate in the surgery of the donor. These two\nsurgeons shall be present for the critical parts of the surgery including the\nlive parenchymal transection. They both shall be available and scrubbed if\nneeded for complications, however, only one surgeon need be present for the\nremainder of the donor operation. (ii)\nA third liver transplant attending\nsurgeon shall be present in the recipient operating room. This surgeon must\nhave experience in deceased liver transplantation. (iii)\n\nAll three surgeons shall be board\ncertified or board admissible in general surgery or have foreign certification\ndetermined to be equivalent by the New York State Department of\n\nHealth. (iv)\n\nAll three surgeons\nshall have demonstrated experience in liver transplant surgery. (v) One of the two surgeons must demonstrate\nexperience as the primary surgeon or first assistant in 20 major hepatic\nsurgeries (to include living donor hepatectomies or major hepatic resections), seven of which must have been live donor hepatectomies within the prior five\nyear period. The other of the two surgeons must be either a liver transplant\nsurgeon or hepatobiliary surgeon practicing at a transplant hospital and must\nhave performed at least 20 major liver resections within the prior five year\nperiod. Both of the surgeons must be available during the donor hepatic\nresection. (2)\n\nAnesthesia\nrequirements: (i) there shall be two separate\nattending anesthesiologists; one each for the living adult liver\ntransplantation donor and recipient operations. These anesthesiologists shall\nbe present for the critical anesthetic and surgical portions of the procedures\nand immediately available at all other times. As one case is completed, either\nanesthesiologist may take responsibility for the ongoing case. The\nanesthesiologists shall have experience in liver transplant anesthesia and/or\nmajor hepatic resection surgery and/or cardiac surgery anesthesia; (ii)\nthere shall be two separate anesthesia\nteams in two operating rooms (one for the donor, one for the recipient); and\n(iii)\nthese teams shall each be\ndirected by a separate attending anesthesiologist for the living donor and the\nrecipient procedure. In addition to the attending anesthesiologist who shall be\npresent as specified in subparagraph (i) of this paragraph, at least one member\nof the anesthesia team who is an anesthesiologist, chief resident, fellow\n(postgraduate year 3, 4, or 5), or qualified certified registered nurse\nanesthetist shall be present and responsible, under the direction of the\nattending anesthesiologist, for the evaluation and care of the patient through\nall phases of the procedure pertaining to the administration of, and recovery\nfrom, anesthesia. All team members shall have ongoing education and training in\nliver and/or cardiac surgery and have had anesthesia responsibility for major\nliver resections. (3)\n\nPostoperative care requirements. Donors shall receive postoperative care\nconsistent with the following: (i) day 0-1. Living adult liver donors shall receive intensive care (ICU or PACU) for at\nleast 24 hours, at a minimum; (ii)\nday 2. If stable and cleared for transfer by the transplant team after the\nfirst 24 hour period, donors shall be cared for in a hospital unit that is\ndedicated to the care of transplant recipients or a hospital unit in which\npatients who undergo major hepatobiliary resectional surgery are cared for. Living liver donors may be cared for on another unit if a specific medical\ncondition of the donor warrants such a transfer and the transfer is documented\nin the donor's medical record; (iii)\nthe donor shall be evaluated at least\ndaily by one of the qualified liver transplant attending physicians with\ndocumentation in the medical record; (iv)\nthe transplant team shall be responsible\nfor the pain management of the donor. In institutions where a pain management\nteam is available, the transplant team may delegate its responsibility to this\nteam. However, there shall be a written protocol in place for assessment and\nmanagement of donor pain; (v) the\npatient care staff shall be familiar with the common complications associated\nwith the donor and recipient operations and have appropriate monitoring in\nplace to detect these problems should they arise; and\n(vi)\nif there is an emergent complication\nrequiring reoperation, these patients shall be prioritized by the hospital for\naccess to the operating room by the institution. (4)\n\nMinimum Medical Staffing Requirements. (i) There shall be 24-hour, seven day-a-week\ncontinuous coverage of the transplant service by general surgery residents at\nthe postgraduate year two level or higher, transplant fellows, nurse\npractitioners or physician assistants. Between the hours of 6 p.m. and 8 a.m. on weekdays and at all times on the weekends and holidays, the covering\nresidents, fellows, nurse practitioners, or physician assistants should be\ndedicated to the transplant service and not covering other surgical or\nnonsurgical patients. An attending transplant surgeon shall be available\nimmediately as a resource for the residents, fellows, nurse practitioners or\nphysician assistants at all times. (ii)\n\nAny patient with abnormal vital signs or\nunusual symptoms shall be evaluated immediately. Notification to the\nappropriate senior medical staff member (fellow, chief resident, attending)\nshall be made in accordance with written hospital policy and procedures and in\nno case no more than 30 minutes after abnormal vital signs or unusual symptoms\nwere first observed. (5)\n\nNursing Minimum Staffing Requirements. Nurse staffing shall be in accordance\nwith the annual clinical staffing plan established under paragraph (8) of\nsubdivision (a) of section\n405.5\nof this Title. In addition: (i) Nursing staff shall have ongoing\neducation and training in live donor liver transplantation nursing care (donor\nand recipient). This shall include education in the pain management issues\nparticular to the donor. The registered professional nursing ratio shall be at\nleast one registered professional nurse for every two patients (1:2) in the\nICU/PACU level setting, increased as appropriate for the acuity level of the\npatients. (ii)\n\nAfter the donor is\ntransferred from the ICU/PACU, the registered professional nursing ratio shall\nbe at least 1:4 on all shifts, increased as appropriate for the acuity level of\nthe patients\n(iii)\n\nThe same\nregistered professional nurse shall not take care of both the donor and the\nrecipient. (iv)\n\nThe nursing service\nshall verify that the potential donor received appropriate pre-surgical\ninformation. (v) The names and\ncontact numbers of the transplant team shall be posted on all units receiving\ntransplant donors. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n405.31\n\nAmended by\n\nNew\n\nYork State Register September 10, 2014/Volume XXXVI, Issue 36, eff. 9/10/2014. Amended\n\nNew\n\nYork State Register November 13, 2019/Volume XLI, Issue 46, eff. 11/13/2019\n\nAmended\n\nNew\n\nYork State Register July 19, 2023/Volume XLV, Issue 29, eff. 7/19/2023\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 32097
}